Come up with a name for your new list and we'll add to it:
Acerta Pharma raised a round of funding on May 01, 2015. Investors include
T. Rowe Price.
Acerta Pharma, a privately-owned biotech company that combines two technology platforms in drug discovery and development: the Covalent Technology Platform and the Multiparametric Phosphoflow Cytometr…